A ugust Troendle is an American physician and entrepreneur who is the founder, President, and CEO of Medpace, a leading contract research organization (CRO). CROs provide support to the pharmaceutical and biotechnology industries in the form of outsourced research services for clinical trials. After earning his medical degree, Troendle worked as a medical officer at the U.S. Food and Drug Administration (FDA), where he gained deep insights into the drug development and approval process.

He founded Medpace in 1992, leveraging his medical and regulatory expertise to build a company that could effectively manage complex clinical trials for drug and medical device companies. As CEO, he has led the company for over three decades, growing it from a small startup into a major publicly traded global enterprise. He is known for his hands-on leadership style and his deep involvement in the company's operations. His success is built on providing the critical, specialized services that help bring new medical treatments to market.